Hassan, A., Kungyal, T., Zhou, S., Blati, M., Finnson, K., Bertos, N., . . . Philip, A. IL-6-mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL-6 receptor-alpha and activation of STAT3/NRF2 pathway. BMC.
Chicago Style (17th ed.) CitationHassan, Amani, et al. IL-6-mediated Tumorigenicity and Antioxidant State in Squamous Cell Carcinoma Cells Are Driven by CD109 via Stabilization of IL-6 Receptor-alpha and Activation of STAT3/NRF2 Pathway. BMC.
MLA (9th ed.) CitationHassan, Amani, et al. IL-6-mediated Tumorigenicity and Antioxidant State in Squamous Cell Carcinoma Cells Are Driven by CD109 via Stabilization of IL-6 Receptor-alpha and Activation of STAT3/NRF2 Pathway. BMC.
Warning: These citations may not always be 100% accurate.